Lilly: Experts concerned over promotional strategies of Eli Lilly for tirzepatide
As Mounjaro (tirzepatide), the blockbuster diabetes and weight loss drug from Eli Lilly, enters the Indian market, serious concerns have been raised over the pharmaceutical giant's promotional strategies. Experts are
Read full article »
Lilly is a Massachusetts-based pharmaceutical company that develops, produces and markets pharmaceutical products for healthcare professionals, patients and consumers.
Read more